FDA Approves Additional Treatment for Adults and Adolescents with Hemophilia A or B and Inhibitors
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Sevenfact [coagulation factor VIIa (recombinant)-jncw] for the treatment and control of bleeding episodes occurring in adults and adolescents 12 years …
Read More